MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome (0916-005)

NCT00543595 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Metabolic Syndrome

Interventions

DRUG: MK0916

Sponsor

Merck Sharp & Dohme LLC